Stratos Genomics (Seattle, WA) a development-stage device company focused on a ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics, closed a $2.1M Series A financing, bringing the total round to $6.1M. Participants have included Fisk Ventures.

The 2Q11 OnBioVC Trend Analysis will be published on Tue 6 September. Advertising opportunities are still available. Reach >45,000 high-value targeted life science professionals on-line and in-print. Contact arubenstein@rnaventures.com for details.